PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Application Notes

The Benefits of 5,000L Single-use Bioreactors for Biologics Manufacturing 

Executive Summary  The entry of the 5,000L single-use bioreactor (SUB) into biologics manufacturing is providing an important bridge between small-scale and ...
Continue Reading →
Volume 7 Issue 4

Moving Closer to Affordable Advanced Therapies: A Review of Current Trends in Downstream Processing 

Viral vectors are a crucial tool within the advanced therapy sector, providing an elegant solution for gene delivery in areas such as gene therapy and vaccine develo...
Continue Reading →
Volume 7 Issue 4

Innovation for the Few: Key Development to Commercialisation Considerations for Drug-Device Combination Products in Rare Diseases 

Developing drug-device combination products for rare diseases presents unique challenges and opportunities for biopharmaceutical companies. These advanced drug deliv...
Continue Reading →
Volume 7 Issue 4

Stability Secured: Leveraging Technology and Expertise to Protect Clinical Trial Supply 

Complex biologics and next-generation cell and gene therapies demand precision handling to maintain stability and promote optimised and patient centric clinical tria...
Continue Reading →
Volume 7 Issue 4

Particulates in Cell and Gene Therapies 

Over the past few months, I’ve had numerous conversations at work and conferences about particulates in cell and gene therapies. These discussions have highlighted t...
Continue Reading →
Volume 7 Issue 4

Exploring Cell & Gene Therapies Through the Ages: How Past Cell and Gene Advancements are Shaping Tomorrow’s Medicines 

Cell and gene therapies (C&GTs) are revolutionising medicine, offering the tantalising prospect of cures for diseases once considered incurable. This remarkable ...
Continue Reading →
Volume 7 Issue 4

Delivering the Future: Overcoming Shipping Challenges in Cell and Gene Therapy 

The rise of cell and gene therapy (CGT) is revolutionising how we treat complex diseases, offering life-changing treatments for patients in need. However, with these...
Continue Reading →
Volume 7 Issue 4

Overcoming Portal Fatigue in Cell and Gene Therapies: Optimising Orchestration

Frustration, exhaustion, and a sense of being overwhelmed – these are the hallmarks of “portal fatigue”, a growing problem for approved treatment center (ATC) staff ...
Continue Reading →